This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Calcifediol (vitamin D) appears to improve outcomes in COVID-19
Read more
Significant weight loss achieved by semaglutide in obese patients without diabetes
Read more
Severe COVID-19 after re-infection with South African variant
Read more
Tocilizumab provides additional benefits to steroids in COVID-19
Read more
Genomic analysis reveals few significant spike protein mutations in COVID-19
Read more
Prediabetes in older adults not prognostic for type 2 diabetes
Read more
Analysis of yellow cards indicates no additional safety concerns with COVID-19 vaccines
Read more
Increased risk of asthma with PPI use in children
Read more
NICE supports use of delafloxacin for hospitalised patients with severe skin infections
Read more
Globally, breast cancer now most common form of the disease
Read more
Immunoglobulin and methylprednisolone effective for multisystem inflammatory syndrome in children
Read more
Huge variation in drug-drug interactions among hospitalised elderly patients
Read more
Systemic corticosteroids only reduce mortality in those critically ill with COVID-19
Read more
COVID-19 antibodies detected in most patients up to six months later
Read more
Tele-health seen as time-efficient during COVID-19 according to those with skin conditions
Read more
Nivolumab improves survival in patients with mesothelioma
Read more
40,000 fewer people in the UK starting cancer treatment during the COVID-19 pandemic
Read more
Page 81 of 200
« First
«
...
10
20
30
...
79
80
81
82
83
...
90
100
110
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: